◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › AMIX

Autonomix Medical, Inc. (AMIX) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-07-24

Autonomix Medical, Inc. (AMIX) operates in the Medical Devices industry and is headquartered in The Woodlands, United States. Its market capitalization is roughly $2 million. In the fiscal year ended 2026-03-31, AMIX reported $0M in revenue and ($17M) in net income.

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system.

Interactive charts & full statements →

AMIX Revenue & Earnings History — Annual Income Statement

Income statement2026-03-312025-03-312024-03-312023-03-31
Total Revenue$0M$0M$0M$0M
Operating Income (EBIT)($17M)($12M)($8M)($2M)
Net Income($17M)($11M)($15M)($2M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AMIX Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$0M$0M$0M$0M$0M
Operating Income (EBIT)($3M)($3M)($8M)($3M)($3M)
Net Income($3M)($3M)($8M)($3M)($3M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AMIX Free Cash Flow History

AMIX Balance Sheet History

Balance sheet2026-03-312025-03-312024-03-312023-03-31
Total Assets$8M$10M$9M$1M
Total Liabilities$2M$2M$2M$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AMIX viewer.

Other Companies in Medical Devices

← AMGNAll stocksAMKR →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.